Skip to main content
NewslettersWatchlist

Evome Medical Technologies Inc(EVMT-X)
TSX Venture

Today's Change
Delayed Last Update
Day Low0.005
Day High0.005
Open:0.005
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

TOP STORIES: Evome Medical Technologies Inc

Select a category then submit the form to load news
AI-generated - The Globe and Mail
Evome Medical: Top 10 Undervalued Medical Devices & Instruments Industry Stocks (EVMT)
PR Newswire
Canadian Investment Regulatory Organization Trading Halt - EVMT
GlobeNewswire
Michael Dalsin Resigns as Chairman of the Board of Directors of Evome Medical Technologies
GlobeNewswire
Evome Medical Technologies Provides Market Update
GlobeNewswire
Evome Medical Technologies Appoints Michael Dalsin as Chairman of the Board of Directors; Increases Size of Board to Six
GlobeNewswire
CLARIFICATION: Evome Medical Technologies Announces Significant Debt Restructuring
GlobeNewswire
Evome Medical Technologies Announces Significant Debt Reduction and Restructuring
GlobeNewswire
Evome Medical Technologies Grants Restricted Stock Units to New Chief Operating Officer
GlobeNewswire
Evome Medical Technologies Posts Third Quarter 2024 Results, Generates $424,000 in Adjusted EBITDA on Stable Revenues, Further Reduces Debt
GlobeNewswire
Evome Medical Technologies Announces Results From Its Annual General and Special Meeting of Shareholders
AI-generated - The Globe and Mail
Evome Medical: Top 10 Undervalued Medical Devices & Instruments Industry Stocks (EVMT)
GlobeNewswire
Evome Medical Technologies Reviews Highlights of Low-CapEx Revenue Growth Plan
GlobeNewswire
Evome Medical Technologies Reports Second Quarter 2024 Financial Results
AI-generated - The Globe and Mail
Evome Medical: Top 10 Undervalued Medical Devices & Instruments Industry Stocks (EVMT)
AI-generated - The Globe and Mail
Evome Medical: Top 25 Undervalued TSX Venture Exchange Stocks (EVMT)
GlobeNewswire
Evome Medical Technologies Retains irlabs for Investor Relations Services
GlobeNewswire
Evome Medical Technologies Announces Securities Issuances
GlobeNewswire
Evome Medical Technologies Announces Update Call with CEO Mike Seckler for Tuesday, June 4, 2024; Provides Update on Strong Q2
GlobeNewswire
Evome Medical Technologies Announces Biodex Generated 100% Sales Growth Comparing April 2024 to January 2024, Plans to Shed Remaining Non-Core Units to Pay Off Remaining Acquisition Debt
GlobeNewswire
Evome Strengthens Major Creditor Relationship After the Sale of the Simbex Unit to Riddell, LOI Related to Simbex Acquisition Debt is Cancelled
GlobeNewswire
Evome Sells Simbex R&D Business Unit to Riddell for $4.83M in Cash; Improves Balance Sheet, Reduces Biodex Acquisition Debt
GlobeNewswire
Evome Medical Technologies Punctuates Turn Around Plan with Strong Fourth Quarter Resulting in Positive Annual Adjusted EBITDA for Fiscal Year 2023
GlobeNewswire
Evome Medical Engages ICP Securities Inc. for Automated Market Making Services
GlobeNewswire
Evome Medical Technologies Bolsters Board of Directors with Appointment of Strategic Senior Healthcare Executives Wayne Anderson and Bill Garbarini, Appoints Kenneth Kashkin, MD, as Chairman
GlobeNewswire
Evome Medical Technologies Executes Non-Binding Letter of Intent to Extend Remaining Simbex Acquisition Debt to June 2025; Increases Sales Targets by 7.5% for Biodex Distribution Contracts; Raises Biodex Product Pricing by 2% for 2024
GlobeNewswire
Evome Medical Technologies Reduces Acquisition Debt, Bolsters Management Team to Support SpaceTeck Knee™ and Reactive Step Trainer 2024 Product Roll-Out

Profile

Evome Medical Technologies Inc is a medical device company. It is focused on human performance and rehabilitative solutions.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2025.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2025 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.